Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias
Sponsor: Apple Inc.
A NA clinical study on Arrhythmias, Cardiac and Atrial Fibrillation, this trial is completed. The trial is conducted by Apple Inc. and has accumulated 12 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Dec 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed NA
-
Nov 2020 — Jan 2021 [monthly]
Completed NA
-
Feb 2020 — Nov 2020 [monthly]
Completed NA
-
Nov 2019 — Feb 2020 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2019 — Nov 2019 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Mar 2019 — Sep 2019 [monthly]
Enrolling By Invitation NA
-
Jan 2019 — Mar 2019 [monthly]
Enrolling By Invitation NA
First recorded
Dec 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Apple Inc.
For direct contact, visit the study record on ClinicalTrials.gov .